Long term efficacy of DOTS regimens for tuberculosis: systematic review. (Q36482540)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Long term efficacy of DOTS regimens for tuberculosis: systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Martha Morrow

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Peter W Deutschmann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

4 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

7642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

484-487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

Targets for global tuberculosis control

2 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Exogenous reinfection in tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Scale up: meeting targets in global tuberculosis control

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Fully intermittent dosing with drugs for tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Tuberculosis epidemiology in six provinces of Vietnam after the introduction of the DOTS strategy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2258398

DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India

21 October 2018

1 reference

12 December 2020

Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study

1 reference

12 December 2020

Overview and epidemiological assessment of the current global tuberculosis situation: with an emphasis on tuberculosis control in developing countries

1 reference

12 December 2020

Good news and not such good news

1 reference

12 December 2020

A nested case-control study on treatment-related risk factors for early relapse of tuberculosis

1 reference

12 December 2020

In the treatment of tuberculosis, you get what you pay for...

1 reference

12 December 2020

XDR-TB: entering the post-antibiotic era?

1 reference

12 December 2020

Existing tuberculosis drugs may hold key to shorter treatment

1 reference

12 December 2020

10.1136/BMJ.39463.640787.BE

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18250104%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

PubMed publication ID

18250104

1 reference